The impact of group B Streptococcus prophylaxis on early onset neonatal infections

Keyphrases

• Antibiotic Resistance 100%
• Early-onset Neonatal Infection 100%
• Group B Streptococcus 100%
• Intrapartum Antibiotics 66%
• Risk Factors 33%
• Very Low Birth Weight 33%
• Regression Analysis 33%
• Fungi 33%
• Prophylactic Use 33%
• Penicillin Resistance 33%
• Early Onset 33%
• Microorganisms 33%
• Multidrug-resistant Pathogens 33%
• Male Gender 33%
• Ampicillin Resistance 33%
• Ampicillin 33%
• Group B Streptococcus Infection 33%
• Antibiotic Sensitivity 33%
• Multidrug-resistant Microorganisms 33%
• Causative Pathogen 33%
• Cerebrospinal Fluid Culture 33%
• Pathogen Resistance 33%

Medicine and Dentistry

• Pathogen 100%
• Newborn Infection 100%
• Streptococcus Agalactiae 100%
• Antibiotics 60%
• Antibiotic Resistance 60%
• Intrapartum 40%
• Very Low Birth Weight 20%
• Penicillin Derivative 20%
• Ampicillin 20%
• Antibiogram 20%
• Group B Streptococcal Infection 20%
• Cerebrospinal Fluid Culture 20%
• Ampicillin Resistance 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Infectious Agent 100%
• Newborn Infection 100%
• Streptococcus Agalactiae 100%
• Antibiotics 80%
• Antibiotic Resistance 60%
• Microorganism 40%
• Ampicillin 40%
• Very Low Birth Weight 20%
• Penicillin Derivative 20%
• Group B Streptococcal Infection 20%